BioNTech SE (BNTXN)
BMV
1,960.00
+160.00 (+8.89%)
Closed
Aug 21, 2026
Day's Range
1,960.001,960.00
52 wk Range
1,456.732,100.00
Financial Statements - BNTXN - BioNTech SE
Revenue
2.86B
Net Income
-1.13BNet Margin -39.6%
EBITDA
-256.30M
Free Cash Flow
-293.00M
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 2.86B |
| Cost of Goods | 641.80M |
| Gross Profit | 2.22B |
 Operating Expense | - |
| Operating Income | -640.70M |
| Non-Operating Interest | - |
| Other Income Expense | -397.50M |
| Pre Tax Income | -1.05B |
| Income Tax | 85.30M |
| Net Income | -1.13B |
| EPS Basic | -4.7 |
| EPS Diluted | -4.7 |
| Basic Shares Outstanding | 241.70M |
| Diluted Shares Outstanding | 241.70M |
| Ebit | -1.03B |
| Ebitda | -256.30M |
| Net Income Continuous Operations | -1.05B |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
